Reactivity patterns of antibodies with DAU samples
| Pattern3-150 . | Anti-D tested3-151 . | DAU-phenotype3-152 . | |||||
|---|---|---|---|---|---|---|---|
| 1-9 . | 1-37 . | IgG . | IgM . | DAU-0 . | DAU-1 . | DAU-2 . | DAU-4 . |
| 1 | 1 | 82, 123 | + | − | + | − | |
| 1 | 2 | 79 | + | − | + | − | |
| 83 | + | − | − | − | |||
| 2 | 3 | 44, 51 | + | + | + | − | |
| 2 | 4 | 48 | + | − | − | − | |
| 3 | 5 | 43, 49, 75 | + | + | + | + | |
| 4 | 6 | 45 | + | + | + | + | |
| 5 | 7 | 42, 116 | + | − | − | − | |
| 5 | 10 | 88, 89 | + | + | + | + | |
| 41 | + | − | + | − | |||
| 52 | + | − | − | − | |||
| 5 | 11 | 69 | + | − | − | − | |
| 6/7 | 12 | 102 | + | − | + | + | |
| 46 | + | − | + | − | |||
| 113 | + | − | − | + | |||
| 35 | + | − | − | − | |||
| 6/7 | 13 | 29, 36, 47, 90, 93, 105 | + | + | + | + | |
| 6/7 | 15/16 | 31, 32, 71, 80, | + | + | + | + | |
| 56, 58, 81, 95, 97, 114 | + | + | + | − | |||
| 108 | + | − | + | + | |||
| 59 | + | − | + | − | |||
| 6/7 | 17 | 37 | + | − | − | + | |
| 28, 34, 39, 98, 99, 115, 134 | + | − | − | − | |||
| 6/7 | 18 | 30 | + | + | + | + | |
| 119 | + | + | − | + | |||
| 84, 85, 86, 87, 100 | + | − | − | − | |||
| 6/7 | 20/21 | 33 | + | + | + | + | |
| 94 | + | + | + | − | |||
| 122 | + | − | + | − | |||
| 61 | + | − | − | − | |||
| 8 | 22 | 74, 78 | + | + | + | + | |
| 9 | 23 | 77, 96, 101, 112, 118, 120, 121 | + | + | + | + | |
| 97 | + | + | + | − | |||
| N/A | 31 | 54, 57 | + | − | − | − | |
| N/A | 32 | 62 | + | − | + | − | |
| N/A | 33 | 38 | + | − | − | − | |
| N/A | 34 | 50 | + | − | + | − | |
| N/A | 35 | 60 | + | − | + | − | |
| N/A | 36 | 55, 72, 76 | + | + | + | + | |
| 53 | + | − | + | − | |||
| N/A | 37 | 68, 73, 117, 124, 180 | + | + | + | + | |
| Pattern3-150 . | Anti-D tested3-151 . | DAU-phenotype3-152 . | |||||
|---|---|---|---|---|---|---|---|
| 1-9 . | 1-37 . | IgG . | IgM . | DAU-0 . | DAU-1 . | DAU-2 . | DAU-4 . |
| 1 | 1 | 82, 123 | + | − | + | − | |
| 1 | 2 | 79 | + | − | + | − | |
| 83 | + | − | − | − | |||
| 2 | 3 | 44, 51 | + | + | + | − | |
| 2 | 4 | 48 | + | − | − | − | |
| 3 | 5 | 43, 49, 75 | + | + | + | + | |
| 4 | 6 | 45 | + | + | + | + | |
| 5 | 7 | 42, 116 | + | − | − | − | |
| 5 | 10 | 88, 89 | + | + | + | + | |
| 41 | + | − | + | − | |||
| 52 | + | − | − | − | |||
| 5 | 11 | 69 | + | − | − | − | |
| 6/7 | 12 | 102 | + | − | + | + | |
| 46 | + | − | + | − | |||
| 113 | + | − | − | + | |||
| 35 | + | − | − | − | |||
| 6/7 | 13 | 29, 36, 47, 90, 93, 105 | + | + | + | + | |
| 6/7 | 15/16 | 31, 32, 71, 80, | + | + | + | + | |
| 56, 58, 81, 95, 97, 114 | + | + | + | − | |||
| 108 | + | − | + | + | |||
| 59 | + | − | + | − | |||
| 6/7 | 17 | 37 | + | − | − | + | |
| 28, 34, 39, 98, 99, 115, 134 | + | − | − | − | |||
| 6/7 | 18 | 30 | + | + | + | + | |
| 119 | + | + | − | + | |||
| 84, 85, 86, 87, 100 | + | − | − | − | |||
| 6/7 | 20/21 | 33 | + | + | + | + | |
| 94 | + | + | + | − | |||
| 122 | + | − | + | − | |||
| 61 | + | − | − | − | |||
| 8 | 22 | 74, 78 | + | + | + | + | |
| 9 | 23 | 77, 96, 101, 112, 118, 120, 121 | + | + | + | + | |
| 97 | + | + | + | − | |||
| N/A | 31 | 54, 57 | + | − | − | − | |
| N/A | 32 | 62 | + | − | + | − | |
| N/A | 33 | 38 | + | − | − | − | |
| N/A | 34 | 50 | + | − | + | − | |
| N/A | 35 | 60 | + | − | + | − | |
| N/A | 36 | 55, 72, 76 | + | + | + | + | |
| 53 | + | − | + | − | |||
| N/A | 37 | 68, 73, 117, 124, 180 | + | + | + | + | |
+ indicates a positive result, − a negative result.
Pattern as described previously by Lomas et al42 (1-9) and Scott11 (1-37), who did not differentiate epitopes 15 from 16 and epitopes 20 from 2111Tab1.
Antibody numbers as defined in “Materials and methods.” Reactivity was tested in a gel matrix test.
DAU-3 was not tested because of a positive direct antiglobulin test (DAT).